Difficulty: Medium
Average Score: 88%
Practice
Tyramine induces release of noradrenaline from adrenergic nerve endings
Correct answer
C
Rationale
The correct answer is C) By a nonexocytotic process.
In the context of the release of noradrenaline from adrenergic nerve endings, the process induced by tyramine is nonexocytotic. This means that tyramine does not cause the release of noradrenaline through the typical process of vesicle fusion and exocytosis. Instead, tyramine acts by displacing noradrenaline from intracellular storage sites, leading to its release into the synaptic cleft through a process that does not involve vesicle fusion.
Option A) By depolarizing the axonal membrane is incorrect because tyramine does not induce noradrenaline release by causing depolarization of the axonal membrane. The mechanism is different.
Option B) By mobilizing Ca2+ is incorrect because tyramine-induced noradrenaline release does not primarily involve the mobilization of calcium ions. While calcium does play a role in neurotransmitter release in general, it is not the primary mechanism in this case.
Option D) Only in the presence of MAO inhibitors is incorrect because tyramine can induce noradrenaline release regardless of the presence of monoamine oxidase (MAO) inhibitors. MAO inhibitors are more related to the breakdown of noradrenaline rather than its release.
In an educational context, understanding the mechanisms of neurotransmitter release is crucial in pharmacology, especially when studying drugs that impact the peripheral nervous system. Knowing how tyramine influences noradrenaline release can provide insights into its effects and potential interactions with other drugs or conditions that may affect neurotransmitter dynamics. This knowledge is important for healthcare professionals when managing patients receiving medications that impact the peripheral nervous system.
In the context of the release of noradrenaline from adrenergic nerve endings, the process induced by tyramine is nonexocytotic. This means that tyramine does not cause the release of noradrenaline through the typical process of vesicle fusion and exocytosis. Instead, tyramine acts by displacing noradrenaline from intracellular storage sites, leading to its release into the synaptic cleft through a process that does not involve vesicle fusion.
Option A) By depolarizing the axonal membrane is incorrect because tyramine does not induce noradrenaline release by causing depolarization of the axonal membrane. The mechanism is different.
Option B) By mobilizing Ca2+ is incorrect because tyramine-induced noradrenaline release does not primarily involve the mobilization of calcium ions. While calcium does play a role in neurotransmitter release in general, it is not the primary mechanism in this case.
Option D) Only in the presence of MAO inhibitors is incorrect because tyramine can induce noradrenaline release regardless of the presence of monoamine oxidase (MAO) inhibitors. MAO inhibitors are more related to the breakdown of noradrenaline rather than its release.
In an educational context, understanding the mechanisms of neurotransmitter release is crucial in pharmacology, especially when studying drugs that impact the peripheral nervous system. Knowing how tyramine influences noradrenaline release can provide insights into its effects and potential interactions with other drugs or conditions that may affect neurotransmitter dynamics. This knowledge is important for healthcare professionals when managing patients receiving medications that impact the peripheral nervous system.